Tag: clinical trials

fda-advisors-recommend-eli-lillys-alzheimers-drug-donanemab-paving-way-for-approval

FDA advisors recommend Eli Lilly’s Alzheimer’s drug donanemab, paving way for approval

Breakthrough FDA Recommendation for Eli Lilly's Alzheimer's Drug DonanemabEli Lilly, a pharmaceutical company based in Indianapolis, Indiana, received a positive recommendation from a panel of independent advisors to the Food and Drug Administration for...

BREAKING NEWS

Top News